Other Species / Isoforms
  HSPC274 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S4-p
____MMPsRTNLATG
Upstream
0 1
Treatment
  • nocodazole
HSPC274 (human) ____MMPsRTNLATG S4-p
HSPC274 iso2 (human) CQRVMMPSRTNLATG S67
HSPC274 (mouse) ____MMPSRTNLATG S4
HSPC274 (rat) ____MMPSRTNLATG S4
S14-p
NLATGIPsskVkysR
0 4
HSPC274 (human) NLATGIPsskVkysR S14-p
HSPC274 iso2 (human) NLATGIPSSKVKYSR S77
HSPC274 (mouse) NLATGLPSSkVKySR S14
HSPC274 (rat) NLATGIPSSKVKYSR S14
S15-p
LATGIPsskVkysRL
0 3
HSPC274 (human) LATGIPsskVkysRL S15-p
HSPC274 iso2 (human) LATGIPSSKVKYSRL S78
HSPC274 (mouse) LATGLPSSkVKySRL S15
HSPC274 (rat) LATGIPSSKVKYSRL S15
K16-ub
ATGIPsskVkysRLs
0 56
HSPC274 (human) ATGIPsskVkysRLs K16-ub
HSPC274 iso2 (human) ATGIPSSKVKYSRLS K79
HSPC274 (mouse) ATGLPSSkVKySRLA K16-ub
HSPC274 (rat) ATGIPSSKVKYSRLS K16
K18-ub
GIPsskVkysRLsst
0 2
HSPC274 (human) GIPsskVkysRLsst K18-ub
HSPC274 iso2 (human) GIPSSKVKYSRLSST K81
HSPC274 (mouse) GLPSSkVKySRLAst K18
HSPC274 (rat) GIPSSKVKYSRLSsT K18
Y19-p
IPsskVkysRLsstD
0 15
HSPC274 (human) IPsskVkysRLsstD Y19-p
HSPC274 iso2 (human) IPSSKVKYSRLSSTD Y82
HSPC274 (mouse) LPSSkVKySRLAstD Y19-p
HSPC274 (rat) IPSSKVKYSRLSsTD Y19
S20-p
PsskVkysRLsstDD
0 5
HSPC274 (human) PsskVkysRLsstDD S20-p
HSPC274 iso2 (human) PSSKVKYSRLSSTDD S83
HSPC274 (mouse) PSSkVKySRLAstDD S20
HSPC274 (rat) PSSKVKYSRLSsTDD S20
S23-p
kVkysRLsstDDGyI
Upstream
0 117
Treatment
  • ischemia
HSPC274 (human) kVkysRLsstDDGyI S23-p
HSPC274 iso2 (human) KVKYSRLSSTDDGYI S86
HSPC274 (mouse) kVKySRLAstDDGyI A23
HSPC274 (rat) KVKYSRLSsTDDGYI S23
S24-p
VkysRLsstDDGyID
Upstream
0 251
Treatment
  • EGF
  • metastatic potential
  • nocodazole
  • SB202190
  • Su11274
view more >
HSPC274 (human) VkysRLsstDDGyID S24-p
HSPC274 iso2 (human) VKYSRLSSTDDGYID S87
HSPC274 (mouse) VKySRLAstDDGyID S24-p
HSPC274 (rat) VKYSRLSsTDDGYID S24-p
T25-p
kysRLsstDDGyIDL
Upstream
0 64
Treatment
  • metastatic potential
HSPC274 (human) kysRLsstDDGyIDL T25-p
HSPC274 iso2 (human) KYSRLSSTDDGYIDL T88
HSPC274 (mouse) KySRLAstDDGyIDL T25-p
HSPC274 (rat) KYSRLSsTDDGYIDL T25
Y29-p
LsstDDGyIDLQFkK
0 72
HSPC274 (human) LsstDDGyIDLQFkK Y29-p
HSPC274 iso2 (human) LSSTDDGYIDLQFKK Y92
HSPC274 (mouse) LAstDDGyIDLQFkK Y29-p
HSPC274 (rat) LSsTDDGYIDLQFKK Y29
K35-ub
GyIDLQFkKTPPKIP
0 2
HSPC274 (human) GyIDLQFkKTPPKIP K35-ub
HSPC274 iso2 (human) GYIDLQFKKTPPKIP K98
HSPC274 (mouse) GyIDLQFkKSPPKIP K35-ub
HSPC274 (rat) GYIDLQFKKSPPKIP K35
Y43-p
KTPPKIPyKAIALAT
0 1
HSPC274 (human) KTPPKIPyKAIALAT Y43-p
HSPC274 iso2 (human) KTPPKIPYKAIALAT Y106
HSPC274 (mouse) KSPPKIPYKAIALAT Y43
HSPC274 (rat) KSPPKIPYKAIALAT Y43
S104-p
LRIAYYAsKGYRGys
0 1
HSPC274 (human) LRIAYYAsKGYRGys S104-p
HSPC274 iso2 (human) LRIAYYASKGYRGYS S167
HSPC274 (mouse) LRIAYYASKGYRGYS S104
HSPC274 (rat) LRIAYYASKGYRGYS S104
Y110-p
AsKGYRGysyDDIPD
0 1
HSPC274 (human) AsKGYRGysyDDIPD Y110-p
HSPC274 iso2 (human) ASKGYRGYSYDDIPD Y173
HSPC274 (mouse) ASKGYRGYSYDDIPD Y110
HSPC274 (rat) ASKGYRGYSYDDIPD Y110
S111-p
sKGYRGysyDDIPDF
0 1
HSPC274 (human) sKGYRGysyDDIPDF S111-p
HSPC274 iso2 (human) SKGYRGYSYDDIPDF S174
HSPC274 (mouse) SKGYRGYSYDDIPDF S111
HSPC274 (rat) SKGYRGYSYDDIPDF S111
Y112-p
KGYRGysyDDIPDFD
0 1
HSPC274 (human) KGYRGysyDDIPDFD Y112-p
HSPC274 iso2 (human) KGYRGYSYDDIPDFD Y175
HSPC274 (mouse) KGYRGYSYDDIPDFD Y112
HSPC274 (rat) KGYRGYSYDDIPDFD Y112